

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 5.99836432 |
| 2 | drug catabolic process (GO:0042737) | 5.77522722 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 5.07758454 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.73830129 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 4.73830129 |
| 6 | cellular ketone body metabolic process (GO:0046950) | 4.73748109 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 4.56896813 |
| 8 | ketone body metabolic process (GO:1902224) | 4.33199076 |
| 9 | regulation of fibrinolysis (GO:0051917) | 4.23946599 |
| 10 | S-adenosylmethionine metabolic process (GO:0046500) | 4.17786193 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 4.15134390 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.12705389 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 4.12705389 |
| 14 | ethanol oxidation (GO:0006069) | 3.96472833 |
| 15 | drug metabolic process (GO:0017144) | 3.81474762 |
| 16 | cellular glucuronidation (GO:0052695) | 3.75783771 |
| 17 | oxidative demethylation (GO:0070989) | 3.73243845 |
| 18 | regulation of protein activation cascade (GO:2000257) | 3.73222911 |
| 19 | phenylpropanoid metabolic process (GO:0009698) | 3.69819757 |
| 20 | regulation of complement activation (GO:0030449) | 3.63878323 |
| 21 | glucuronate metabolic process (GO:0019585) | 3.63399430 |
| 22 | uronic acid metabolic process (GO:0006063) | 3.63399430 |
| 23 | positive regulation of glycolytic process (GO:0045821) | 3.62983069 |
| 24 | tryptophan catabolic process (GO:0006569) | 3.62960400 |
| 25 | indole-containing compound catabolic process (GO:0042436) | 3.62960400 |
| 26 | indolalkylamine catabolic process (GO:0046218) | 3.62960400 |
| 27 | bile acid biosynthetic process (GO:0006699) | 3.60675799 |
| 28 | regulation of hexokinase activity (GO:1903299) | 3.59049001 |
| 29 | regulation of glucokinase activity (GO:0033131) | 3.59049001 |
| 30 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.44774130 |
| 31 | complement activation, alternative pathway (GO:0006957) | 3.41447913 |
| 32 | negative regulation of protein activation cascade (GO:2000258) | 3.40876714 |
| 33 | bile acid metabolic process (GO:0008206) | 3.37819981 |
| 34 | glyoxylate metabolic process (GO:0046487) | 3.32972508 |
| 35 | negative regulation of complement activation (GO:0045916) | 3.30909046 |
| 36 | heme transport (GO:0015886) | 3.30453975 |
| 37 | flavonoid metabolic process (GO:0009812) | 3.28062420 |
| 38 | ethanol metabolic process (GO:0006067) | 3.23202898 |
| 39 | organic cation transport (GO:0015695) | 3.22904457 |
| 40 | negative regulation of fibrinolysis (GO:0051918) | 3.20405660 |
| 41 | xenobiotic catabolic process (GO:0042178) | 3.11678592 |
| 42 | triglyceride homeostasis (GO:0070328) | 3.10801255 |
| 43 | acylglycerol homeostasis (GO:0055090) | 3.10801255 |
| 44 | coenzyme catabolic process (GO:0009109) | 3.10606856 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 3.09658887 |
| 46 | intestinal cholesterol absorption (GO:0030299) | 3.06898108 |
| 47 | bile acid and bile salt transport (GO:0015721) | 3.06508426 |
| 48 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.99822858 |
| 49 | endocrine pancreas development (GO:0031018) | 2.96910717 |
| 50 | tryptophan metabolic process (GO:0006568) | 2.94702972 |
| 51 | reverse cholesterol transport (GO:0043691) | 2.92311297 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 2.90632468 |
| 53 | protein carboxylation (GO:0018214) | 2.90607013 |
| 54 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.90607013 |
| 55 | high-density lipoprotein particle remodeling (GO:0034375) | 2.90336685 |
| 56 | drug transmembrane transport (GO:0006855) | 2.88746171 |
| 57 | indolalkylamine metabolic process (GO:0006586) | 2.83834884 |
| 58 | alanine transport (GO:0032328) | 2.83403660 |
| 59 | blood coagulation, intrinsic pathway (GO:0007597) | 2.82792572 |
| 60 | macroautophagy (GO:0016236) | 2.82447551 |
| 61 | vitamin biosynthetic process (GO:0009110) | 2.81252254 |
| 62 | aromatic amino acid family metabolic process (GO:0009072) | 2.80536512 |
| 63 | alkaloid metabolic process (GO:0009820) | 2.76759261 |
| 64 | L-methionine salvage (GO:0071267) | 2.74878682 |
| 65 | L-methionine biosynthetic process (GO:0071265) | 2.74878682 |
| 66 | amino acid salvage (GO:0043102) | 2.74878682 |
| 67 | peptide hormone processing (GO:0016486) | 2.74417501 |
| 68 | negative regulation of humoral immune response (GO:0002921) | 2.70632602 |
| 69 | iron coordination entity transport (GO:1901678) | 2.70042446 |
| 70 | cholesterol efflux (GO:0033344) | 2.64903738 |
| 71 | arginine metabolic process (GO:0006525) | 2.64051804 |
| 72 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.63448969 |
| 73 | xenobiotic metabolic process (GO:0006805) | 2.59976731 |
| 74 | protein activation cascade (GO:0072376) | 2.58821122 |
| 75 | dopamine transport (GO:0015872) | 2.58679190 |
| 76 | benzene-containing compound metabolic process (GO:0042537) | 2.58124632 |
| 77 | regulation of energy homeostasis (GO:2000505) | 2.56398267 |
| 78 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.55175957 |
| 79 | cellular response to ethanol (GO:0071361) | 2.54410072 |
| 80 | plasma lipoprotein particle remodeling (GO:0034369) | 2.53554342 |
| 81 | protein-lipid complex remodeling (GO:0034368) | 2.53554342 |
| 82 | macromolecular complex remodeling (GO:0034367) | 2.53554342 |
| 83 | proline transport (GO:0015824) | 2.52731326 |
| 84 | drug transport (GO:0015893) | 2.50653819 |
| 85 | fibrinolysis (GO:0042730) | 2.50624572 |
| 86 | urate metabolic process (GO:0046415) | 2.49754439 |
| 87 | kynurenine metabolic process (GO:0070189) | 2.48492318 |
| 88 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.47885455 |
| 89 | intestinal absorption (GO:0050892) | 2.47448875 |
| 90 | negative regulation of sterol transport (GO:0032372) | 2.46759080 |
| 91 | negative regulation of cholesterol transport (GO:0032375) | 2.46759080 |
| 92 | phospholipid homeostasis (GO:0055091) | 2.46724236 |
| 93 | positive regulation of insulin secretion (GO:0032024) | 2.46623490 |
| 94 | positive regulation of peptide hormone secretion (GO:0090277) | 2.45647120 |
| 95 | primary alcohol metabolic process (GO:0034308) | 2.45335009 |
| 96 | zinc ion homeostasis (GO:0055069) | 2.44924297 |
| 97 | negative regulation of hormone metabolic process (GO:0032351) | 2.44534366 |
| 98 | nitric oxide mediated signal transduction (GO:0007263) | 2.43421652 |
| 99 | retinal metabolic process (GO:0042574) | 2.42806908 |
| 100 | complement activation, classical pathway (GO:0006958) | 2.41048840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.09793476 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.58391626 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.44093088 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.41421999 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.22400255 |
| 6 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.18437854 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11367714 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.11312493 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.07545376 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.94440767 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.93813390 |
| 12 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.86345400 |
| 13 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.82388838 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.78215269 |
| 15 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.75858317 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.74516840 |
| 17 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.74472012 |
| 18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.66936864 |
| 19 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.66156284 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.63731454 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.63578556 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.62762880 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.61483123 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 1.61277599 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.55397448 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55299972 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.53845452 |
| 28 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46758427 |
| 29 | STAT3_23295773_ChIP-Seq_U87_Human | 1.46649335 |
| 30 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.46075885 |
| 31 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.44558500 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.42531283 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41192635 |
| 34 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.40108382 |
| 35 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.38417201 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.37068438 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.36920980 |
| 38 | AR_25329375_ChIP-Seq_VCAP_Human | 1.36846544 |
| 39 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32813666 |
| 40 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.32107945 |
| 41 | TCF4_23295773_ChIP-Seq_U87_Human | 1.31086456 |
| 42 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.29756901 |
| 43 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29240305 |
| 44 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.28593740 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25070713 |
| 46 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.24830112 |
| 47 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.23437489 |
| 48 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22530866 |
| 49 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.21519834 |
| 50 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21324152 |
| 51 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20670155 |
| 52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20491511 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19726463 |
| 54 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.18396775 |
| 55 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.18396775 |
| 56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18288201 |
| 57 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18288201 |
| 58 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.18221847 |
| 59 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.17669418 |
| 60 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16854966 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16680288 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16439577 |
| 63 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15747699 |
| 64 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.14488491 |
| 65 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.13017277 |
| 66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12064053 |
| 67 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.11505822 |
| 68 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.11393644 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11245941 |
| 70 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10162195 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09575106 |
| 72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09152139 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07941138 |
| 74 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.07885494 |
| 75 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.07052336 |
| 76 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.06829426 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05706541 |
| 78 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.05228460 |
| 79 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.05228460 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05120583 |
| 81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04345211 |
| 82 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03704011 |
| 83 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.03672579 |
| 84 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.03561391 |
| 85 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.03291890 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02420015 |
| 87 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02420015 |
| 88 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02336599 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01632856 |
| 90 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01485616 |
| 91 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01484198 |
| 92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01403040 |
| 93 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01097495 |
| 94 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00263287 |
| 95 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99736608 |
| 96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99443700 |
| 97 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.99334418 |
| 98 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98763414 |
| 99 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98038974 |
| 100 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.97290070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.51741624 |
| 2 | MP0003195_calcinosis | 5.09163899 |
| 3 | MP0005365_abnormal_bile_salt | 4.19095578 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 3.63482813 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.60143320 |
| 6 | MP0005360_urolithiasis | 3.22069486 |
| 7 | MP0002876_abnormal_thyroid_physiology | 3.06396465 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.82463208 |
| 9 | MP0003252_abnormal_bile_duct | 2.75613519 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.34748758 |
| 11 | MP0002909_abnormal_adrenal_gland | 2.30313854 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.28816550 |
| 13 | MP0005332_abnormal_amino_acid | 2.25310275 |
| 14 | MP0009780_abnormal_chondrocyte_physiolo | 2.16955458 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.14514665 |
| 16 | MP0003868_abnormal_feces_composition | 2.06070351 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.03332590 |
| 18 | MP0000569_abnormal_digit_pigmentation | 1.97794222 |
| 19 | MP0004043_abnormal_pH_regulation | 1.80292901 |
| 20 | MP0001764_abnormal_homeostasis | 1.76889371 |
| 21 | MP0005379_endocrine/exocrine_gland_phen | 1.75599607 |
| 22 | MP0001501_abnormal_sleep_pattern | 1.67386302 |
| 23 | MP0005645_abnormal_hypothalamus_physiol | 1.67208536 |
| 24 | MP0002693_abnormal_pancreas_physiology | 1.66046422 |
| 25 | MP0005646_abnormal_pituitary_gland | 1.61714576 |
| 26 | MP0001944_abnormal_pancreas_morphology | 1.61697920 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.57029810 |
| 28 | MP0001756_abnormal_urination | 1.56767973 |
| 29 | MP0010386_abnormal_urinary_bladder | 1.56560434 |
| 30 | MP0003011_delayed_dark_adaptation | 1.41842999 |
| 31 | MP0003283_abnormal_digestive_organ | 1.38943033 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.37719065 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.35391505 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 1.33377729 |
| 35 | MP0002078_abnormal_glucose_homeostasis | 1.33068795 |
| 36 | MP0001661_extended_life_span | 1.32561680 |
| 37 | MP0002163_abnormal_gland_morphology | 1.31354103 |
| 38 | MP0001986_abnormal_taste_sensitivity | 1.31140772 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.30962701 |
| 40 | MP0005220_abnormal_exocrine_pancreas | 1.19795612 |
| 41 | MP0008872_abnormal_physiological_respon | 1.17650068 |
| 42 | MP0009046_muscle_twitch | 1.17355242 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 1.16626900 |
| 44 | MP0002254_reproductive_system_inflammat | 1.16366997 |
| 45 | MP0001765_abnormal_ion_homeostasis | 1.15120463 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.14227394 |
| 47 | MP0002928_abnormal_bile_duct | 1.13996606 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.13175414 |
| 49 | MP0003787_abnormal_imprinting | 1.11895722 |
| 50 | MP0005535_abnormal_body_temperature | 1.10172069 |
| 51 | MP0005448_abnormal_energy_balance | 1.09984234 |
| 52 | MP0009840_abnormal_foam_cell | 1.09123953 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.07341268 |
| 54 | MP0000609_abnormal_liver_physiology | 1.04704156 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.03955541 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.00326388 |
| 57 | MP0009745_abnormal_behavioral_response | 0.99643857 |
| 58 | MP0003879_abnormal_hair_cell | 0.97505525 |
| 59 | MP0003953_abnormal_hormone_level | 0.95006588 |
| 60 | MP0003646_muscle_fatigue | 0.92126132 |
| 61 | MP0000427_abnormal_hair_cycle | 0.90144765 |
| 62 | MP0001984_abnormal_olfaction | 0.88983706 |
| 63 | MP0003690_abnormal_glial_cell | 0.88669315 |
| 64 | MP0003633_abnormal_nervous_system | 0.84847770 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 0.83361136 |
| 66 | MP0000538_abnormal_urinary_bladder | 0.82942655 |
| 67 | MP0000015_abnormal_ear_pigmentation | 0.82282992 |
| 68 | MP0003045_fibrosis | 0.82264707 |
| 69 | MP0002168_other_aberrant_phenotype | 0.81069079 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 0.80412506 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.80187879 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 0.79666050 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.79196373 |
| 74 | MP0000230_abnormal_systemic_arterial | 0.77027683 |
| 75 | MP0005386_behavior/neurological_phenoty | 0.76998867 |
| 76 | MP0004924_abnormal_behavior | 0.76998867 |
| 77 | MP0002064_seizures | 0.75755778 |
| 78 | MP0002102_abnormal_ear_morphology | 0.75236047 |
| 79 | MP0005253_abnormal_eye_physiology | 0.73819718 |
| 80 | MP0008775_abnormal_heart_ventricle | 0.73345101 |
| 81 | MP0000371_diluted_coat_color | 0.72036459 |
| 82 | MP0005376_homeostasis/metabolism_phenot | 0.71444460 |
| 83 | MP0002229_neurodegeneration | 0.71375177 |
| 84 | MP0002272_abnormal_nervous_system | 0.69777897 |
| 85 | MP0002166_altered_tumor_susceptibility | 0.69333979 |
| 86 | MP0002971_abnormal_brown_adipose | 0.66869185 |
| 87 | MP0006036_abnormal_mitochondrial_physio | 0.66736019 |
| 88 | MP0004147_increased_porphyrin_level | 0.66679045 |
| 89 | MP0004130_abnormal_muscle_cell | 0.66591650 |
| 90 | MP0005408_hypopigmentation | 0.66071518 |
| 91 | MP0008469_abnormal_protein_level | 0.65800061 |
| 92 | MP0004885_abnormal_endolymph | 0.65255913 |
| 93 | MP0010678_abnormal_skin_adnexa | 0.65232735 |
| 94 | MP0002090_abnormal_vision | 0.64432231 |
| 95 | MP0006054_spinal_hemorrhage | 0.64109206 |
| 96 | MP0004142_abnormal_muscle_tone | 0.61168995 |
| 97 | MP0001664_abnormal_digestion | 0.60766010 |
| 98 | MP0002557_abnormal_social/conspecific_i | 0.60175016 |
| 99 | MP0003724_increased_susceptibility_to | 0.59906254 |
| 100 | MP0006082_CNS_inflammation | 0.59684919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.55863142 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 4.48896460 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 4.15979209 |
| 4 | Hypoglycemic coma (HP:0001325) | 4.00734254 |
| 5 | Ketoacidosis (HP:0001993) | 3.98910054 |
| 6 | Complement deficiency (HP:0004431) | 3.79132774 |
| 7 | Ketosis (HP:0001946) | 3.45596044 |
| 8 | Hypoglycemic seizures (HP:0002173) | 3.41573062 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.35880947 |
| 10 | Hyperglycemia (HP:0003074) | 3.27668417 |
| 11 | Large for gestational age (HP:0001520) | 3.16430236 |
| 12 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.08761229 |
| 13 | Xanthomatosis (HP:0000991) | 3.04854783 |
| 14 | Vascular calcification (HP:0004934) | 3.04521212 |
| 15 | Conjugated hyperbilirubinemia (HP:0002908) | 3.00343902 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 2.99899934 |
| 17 | Hypothermia (HP:0002045) | 2.99661056 |
| 18 | Abnormality of the renal cortex (HP:0011035) | 2.85453866 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.83562885 |
| 20 | Deep venous thrombosis (HP:0002625) | 2.74689638 |
| 21 | Congenital sensorineural hearing impairment (HP:0008527) | 2.67689171 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 2.66456555 |
| 23 | Decreased circulating renin level (HP:0003351) | 2.65504544 |
| 24 | Cardiovascular calcification (HP:0011915) | 2.63511950 |
| 25 | Late onset (HP:0003584) | 2.62747717 |
| 26 | Joint hemorrhage (HP:0005261) | 2.61515815 |
| 27 | Abnormality of complement system (HP:0005339) | 2.61126519 |
| 28 | Glycosuria (HP:0003076) | 2.59081290 |
| 29 | Abnormality of urine glucose concentration (HP:0011016) | 2.59081290 |
| 30 | Fair hair (HP:0002286) | 2.58728668 |
| 31 | Glomerulonephritis (HP:0000099) | 2.56595875 |
| 32 | Abnormality of vitamin metabolism (HP:0100508) | 2.56186666 |
| 33 | Abnormal drinking behavior (HP:0030082) | 2.55787413 |
| 34 | Polydipsia (HP:0001959) | 2.55787413 |
| 35 | Renal cortical cysts (HP:0000803) | 2.54244101 |
| 36 | Proximal tubulopathy (HP:0000114) | 2.51838931 |
| 37 | Hyperventilation (HP:0002883) | 2.49965705 |
| 38 | Fat malabsorption (HP:0002630) | 2.43710673 |
| 39 | Generalized hypopigmentation of hair (HP:0011358) | 2.34010699 |
| 40 | Hypomagnesemia (HP:0002917) | 2.33818130 |
| 41 | Attenuation of retinal blood vessels (HP:0007843) | 2.33743699 |
| 42 | Pancreatic cysts (HP:0001737) | 2.33515051 |
| 43 | Steatorrhea (HP:0002570) | 2.32264163 |
| 44 | Abnormality of vitamin B metabolism (HP:0004340) | 2.32118203 |
| 45 | Abnormality of proline metabolism (HP:0010907) | 2.31845680 |
| 46 | Hydroxyprolinuria (HP:0003080) | 2.31845680 |
| 47 | Increased CSF protein (HP:0002922) | 2.27608900 |
| 48 | Hemiparesis (HP:0001269) | 2.25551820 |
| 49 | Hamartoma of the eye (HP:0010568) | 2.25178181 |
| 50 | Symptomatic seizures (HP:0011145) | 2.22752298 |
| 51 | Mitral stenosis (HP:0001718) | 2.21960108 |
| 52 | Tubular atrophy (HP:0000092) | 2.18969320 |
| 53 | Intrahepatic cholestasis (HP:0001406) | 2.15539738 |
| 54 | Hypolipoproteinemia (HP:0010981) | 2.15284534 |
| 55 | Pancreatic fibrosis (HP:0100732) | 2.14721854 |
| 56 | Congenital stationary night blindness (HP:0007642) | 2.14616158 |
| 57 | Generalized aminoaciduria (HP:0002909) | 2.13915107 |
| 58 | Epidermoid cyst (HP:0200040) | 2.13429014 |
| 59 | Thyroiditis (HP:0100646) | 2.12715009 |
| 60 | Increased circulating renin level (HP:0000848) | 2.10641349 |
| 61 | Abnormality of renin-angiotensin system (HP:0000847) | 2.09872491 |
| 62 | Metabolic alkalosis (HP:0200114) | 2.09547145 |
| 63 | Conjunctival hamartoma (HP:0100780) | 2.09189008 |
| 64 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.07878582 |
| 65 | Intestinal atresia (HP:0011100) | 2.06994774 |
| 66 | Arthropathy (HP:0003040) | 2.06258700 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03027526 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03027526 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03027526 |
| 70 | Bile duct proliferation (HP:0001408) | 2.02546947 |
| 71 | Abnormal biliary tract physiology (HP:0012439) | 2.02546947 |
| 72 | EEG with generalized epileptiform discharges (HP:0011198) | 2.00655923 |
| 73 | Albinism (HP:0001022) | 2.00598162 |
| 74 | Abnormality of renal excretion (HP:0011036) | 2.00310125 |
| 75 | Medial flaring of the eyebrow (HP:0010747) | 2.00257616 |
| 76 | Abnormality of midbrain morphology (HP:0002418) | 1.97845376 |
| 77 | Molar tooth sign on MRI (HP:0002419) | 1.97845376 |
| 78 | Nephronophthisis (HP:0000090) | 1.97426376 |
| 79 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.96986559 |
| 80 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.96986559 |
| 81 | Hypsarrhythmia (HP:0002521) | 1.96965192 |
| 82 | Polyuria (HP:0000103) | 1.96409511 |
| 83 | Abnormal urine output (HP:0012590) | 1.95549606 |
| 84 | Epileptiform EEG discharges (HP:0011182) | 1.94447980 |
| 85 | Furrowed tongue (HP:0000221) | 1.92850492 |
| 86 | Gaze-evoked nystagmus (HP:0000640) | 1.90131405 |
| 87 | True hermaphroditism (HP:0010459) | 1.89643047 |
| 88 | Potter facies (HP:0002009) | 1.89139574 |
| 89 | Facial shape deformation (HP:0011334) | 1.89139574 |
| 90 | Alkalosis (HP:0001948) | 1.88618381 |
| 91 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87409065 |
| 92 | Mucopolysacchariduria (HP:0008155) | 1.87409065 |
| 93 | Hematochezia (HP:0002573) | 1.85065964 |
| 94 | Metabolic acidosis (HP:0001942) | 1.84486527 |
| 95 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.83762862 |
| 96 | Abnormality of the renal medulla (HP:0100957) | 1.83321235 |
| 97 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.83072124 |
| 98 | Vacuolated lymphocytes (HP:0001922) | 1.82244554 |
| 99 | Febrile seizures (HP:0002373) | 1.81399569 |
| 100 | Abolished electroretinogram (ERG) (HP:0000550) | 1.81187968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 8.26412852 |
| 2 | FGFR2 | 2.90017255 |
| 3 | ACVR1B | 2.89593383 |
| 4 | ADRBK2 | 2.81138091 |
| 5 | GRK1 | 2.74565275 |
| 6 | PINK1 | 2.28581847 |
| 7 | DAPK2 | 2.09430227 |
| 8 | TAOK3 | 1.98025294 |
| 9 | INSRR | 1.89132677 |
| 10 | STK24 | 1.88426997 |
| 11 | NTRK3 | 1.84879538 |
| 12 | PHKG1 | 1.84011027 |
| 13 | PHKG2 | 1.84011027 |
| 14 | TRPM7 | 1.80459637 |
| 15 | FGFR3 | 1.76492103 |
| 16 | MAP4K2 | 1.73449180 |
| 17 | MST4 | 1.66936091 |
| 18 | CAMKK2 | 1.59397801 |
| 19 | NLK | 1.51657279 |
| 20 | BMPR1B | 1.50675420 |
| 21 | OXSR1 | 1.47226097 |
| 22 | PTK2B | 1.42782171 |
| 23 | BRSK2 | 1.33782210 |
| 24 | AKT3 | 1.33286921 |
| 25 | PAK3 | 1.32772340 |
| 26 | STK39 | 1.31016150 |
| 27 | WNK3 | 1.28383595 |
| 28 | PRKAA2 | 1.28243222 |
| 29 | MAP3K2 | 1.27996829 |
| 30 | FER | 1.14915258 |
| 31 | HIPK2 | 1.14557778 |
| 32 | WNK4 | 1.13234457 |
| 33 | PRKCE | 1.03546925 |
| 34 | EPHA3 | 1.02744930 |
| 35 | MAP2K6 | 0.99448228 |
| 36 | TNIK | 0.92120946 |
| 37 | PIK3CA | 0.89035977 |
| 38 | TNK2 | 0.88958519 |
| 39 | STK38L | 0.88425596 |
| 40 | TXK | 0.83967841 |
| 41 | NUAK1 | 0.82714530 |
| 42 | STK11 | 0.81040431 |
| 43 | ADRBK1 | 0.80540423 |
| 44 | ERBB3 | 0.79601481 |
| 45 | JAK1 | 0.76579229 |
| 46 | PRKAA1 | 0.74884738 |
| 47 | PRKCG | 0.74511920 |
| 48 | SGK2 | 0.72925832 |
| 49 | TYK2 | 0.72532368 |
| 50 | IRAK1 | 0.72207229 |
| 51 | MAPKAPK3 | 0.69254892 |
| 52 | PIK3CG | 0.69070192 |
| 53 | TIE1 | 0.68857470 |
| 54 | TEC | 0.67146866 |
| 55 | KIT | 0.66355768 |
| 56 | MAP3K4 | 0.65755343 |
| 57 | BMPR2 | 0.65090955 |
| 58 | ITK | 0.62904127 |
| 59 | MAPK15 | 0.62724147 |
| 60 | PRKCQ | 0.62531118 |
| 61 | TLK1 | 0.60148766 |
| 62 | IKBKB | 0.57309167 |
| 63 | PDK1 | 0.55138426 |
| 64 | STK38 | 0.53870397 |
| 65 | MAPK11 | 0.52044208 |
| 66 | ERBB2 | 0.50901057 |
| 67 | STK3 | 0.50013791 |
| 68 | PRKG1 | 0.46755171 |
| 69 | MAPK13 | 0.46715492 |
| 70 | PRKACA | 0.46416998 |
| 71 | MYLK | 0.46371322 |
| 72 | CHUK | 0.44164275 |
| 73 | GRK7 | 0.43793464 |
| 74 | MAP2K1 | 0.43523052 |
| 75 | CAMK2D | 0.42057399 |
| 76 | SGK3 | 0.41405401 |
| 77 | PRKACG | 0.41079566 |
| 78 | PRKD2 | 0.40904091 |
| 79 | PRKCH | 0.40737617 |
| 80 | IKBKE | 0.40559060 |
| 81 | PDPK1 | 0.40482529 |
| 82 | MAP3K7 | 0.40406253 |
| 83 | PRKCA | 0.40182197 |
| 84 | SGK223 | 0.39110139 |
| 85 | SGK494 | 0.39110139 |
| 86 | PRKCZ | 0.38650725 |
| 87 | CASK | 0.37899822 |
| 88 | SYK | 0.36370664 |
| 89 | CSNK1A1 | 0.35772084 |
| 90 | CAMK2A | 0.35586464 |
| 91 | IGF1R | 0.34678081 |
| 92 | TAOK1 | 0.34371308 |
| 93 | OBSCN | 0.34347415 |
| 94 | GSK3A | 0.34162186 |
| 95 | CAMKK1 | 0.33909040 |
| 96 | CSNK1G1 | 0.32952298 |
| 97 | LCK | 0.31096438 |
| 98 | CDC42BPA | 0.28921665 |
| 99 | PLK2 | 0.28635451 |
| 100 | CSNK1D | 0.28579616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.75524549 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.46866029 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.11779862 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.88025531 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.84839894 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.82608755 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 2.69121405 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.43852758 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.42296420 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.38777597 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.30041226 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.25824966 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.12983221 |
| 14 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.11550975 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.06725392 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00503458 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.84555462 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.79388742 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.77841008 |
| 20 | ABC transporters_Homo sapiens_hsa02010 | 1.71096697 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.66109057 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.61562782 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.59677634 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.55299673 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.46642755 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.44957899 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.44419607 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.37946055 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.36976413 |
| 30 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.31515879 |
| 31 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28365052 |
| 32 | Insulin secretion_Homo sapiens_hsa04911 | 1.27816726 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23555770 |
| 34 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17039616 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13542016 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13453362 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.11358753 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.06110426 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03783629 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.03629978 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.03416749 |
| 42 | Mineral absorption_Homo sapiens_hsa04978 | 1.02560511 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99580463 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.98613729 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98007645 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95030701 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94800394 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91777517 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88476798 |
| 50 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82009730 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79592296 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 0.79568076 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78168279 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77010045 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77000402 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75277113 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75143539 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72980772 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72376419 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71888378 |
| 61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.71784954 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70919984 |
| 63 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65809017 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.63569678 |
| 65 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.62578128 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61380882 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60531801 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60501378 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58929335 |
| 70 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56747448 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 0.51740504 |
| 72 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50335784 |
| 73 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47569568 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47087934 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46076286 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45902589 |
| 77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44597024 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41420948 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40996700 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37771724 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.37514367 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36557387 |
| 83 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35869706 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.35175811 |
| 85 | Protein export_Homo sapiens_hsa03060 | 0.35068624 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.34076452 |
| 87 | Salivary secretion_Homo sapiens_hsa04970 | 0.33430627 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32189550 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32092191 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29605657 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29191973 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.25263132 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.24917674 |
| 94 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.23497519 |
| 95 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.22027782 |
| 96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.21806095 |
| 97 | GABAergic synapse_Homo sapiens_hsa04727 | 0.20136772 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.19020077 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18935674 |
| 100 | Cocaine addiction_Homo sapiens_hsa05030 | 0.13822925 |

